Skip to main content
. Author manuscript; available in PMC: 2020 Dec 5.
Published in final edited form as: Lancet HIV. 2019 Dec 6:S2352-3018(19)30337-6. doi: 10.1016/S2352-3018(19)30337-6

Table 4:

Adverse events by randomization arm

Adverse event grades OLA-guided therapy Standard of Care p-value
Grade 1 – Mild 5 (5%) 2 (2%) 0.44
Grade 2 - Moderate 27 (26%) 24 (23%)
Grade 3 – Severe 36 (34%) 29 (28%)
Grade 4 – Life Threatening 3 (3%) 5 (5%)
Grade 5 – Death 34 (32%) 43 (42%)

Abbreviations: OLA, oligonucleotide ligation assay